729 related articles for article (PubMed ID: 27238066)
1. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
McCabe SE; Dickinson K; West BT; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
[TBL] [Abstract][Full Text] [Related]
2. Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
McCabe SE; Figueroa O; McCabe VV; Schepis TS; Schulenberg JE; Veliz PT; Werner KS; Wilens TE
J Child Psychol Psychiatry; 2024 Jan; 65(1):100-111. PubMed ID: 37062713
[TBL] [Abstract][Full Text] [Related]
3. Early exposure to stimulant medications and substance-related problems: The role of medical and nonmedical contexts.
McCabe SE; Veliz P; Boyd CJ
Drug Alcohol Depend; 2016 Jun; 163():55-63. PubMed ID: 27129621
[TBL] [Abstract][Full Text] [Related]
4. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
[TBL] [Abstract][Full Text] [Related]
5. ADHD Medication and Substance-Related Problems.
Quinn PD; Chang Z; Hur K; Gibbons RD; Lahey BB; Rickert ME; Sjölander A; Lichtenstein P; Larsson H; D'Onofrio BM
Am J Psychiatry; 2017 Sep; 174(9):877-885. PubMed ID: 28659039
[TBL] [Abstract][Full Text] [Related]
6. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
[TBL] [Abstract][Full Text] [Related]
7. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
Wilens TE; Faraone SV; Biederman J; Gunawardene S
Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
[TBL] [Abstract][Full Text] [Related]
8. Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.
McCabe SE; Veliz P; Wilens TE; Schulenberg JE
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):226-233.e4. PubMed ID: 28219488
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
10. Adolescents' Use of Medications for Attention-Deficit/Hyperactivity Disorder and Subsequent Risk of Nonmedical Stimulant Use.
McCabe VV; Veliz PT; Wilens TE; Schepis TS; Pasman E; Evans-Polce RJ; McCabe SE
J Adolesc Health; 2024 Jul; 75(1):188-191. PubMed ID: 38483378
[TBL] [Abstract][Full Text] [Related]
11. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
Harty SC; Ivanov I; Newcorn JH; Halperin JM
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):331-9. PubMed ID: 21823914
[TBL] [Abstract][Full Text] [Related]
12. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Kollins SH
Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
[TBL] [Abstract][Full Text] [Related]
13. Attention-deficit/hyperactivity disorder and substance abuse.
Harstad E; Levy S;
Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
[TBL] [Abstract][Full Text] [Related]
14. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
15. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
Byrd HC; Curtin C; Anderson SE
Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
[TBL] [Abstract][Full Text] [Related]
16. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
17. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
18. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
Barkley RA; Fischer M; Smallish L; Fletcher K
Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
[TBL] [Abstract][Full Text] [Related]
19. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
Biederman J; Monuteaux MC; Spencer T; Wilens TE; Macpherson HA; Faraone SV
Am J Psychiatry; 2008 May; 165(5):597-603. PubMed ID: 18316421
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
